Literature DB >> 2416627

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients.

M Ebara, M Ohto, T Shinagawa, N Sugiura, K Kimura, S Matsutani, M Morita, H Saisho, Y Tsuchiya, K Okuda.   

Abstract

Twenty-two patients with cirrhosis and minute hepatocellular carcinoma less than 3 cm in diameter were followed for periods of 6-37 mo without specific treatment. The survival curve drawn by the Kaplan-Meier method showed a 1-yr survival of 90.7%, a 2-yr survival of 55.0%, and a 3-yr survival of 12.8%. The ultrasonic patterns of these masses in the liver were correlated with the size and showed a tendency to change from a low echo pattern to a low periphery and, finally, to a massive pattern. The growth speed calculated from the doubling time for tumor volume varied considerably from case to case with an average of 6.5 +/- 5.7 mo; it also changed in some cases during the observation period. Serum alpha-fetoprotein levels were generally low, rarely assisted in diagnosis, but tended to increase when the mass attained a diameter of greater than 3 cm; sudden acceleration in the rate of increase in alpha-fetoprotein level often coincided with a change of ultrasonic pattern to the massive one.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2416627     DOI: 10.1016/0016-5085(86)90923-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  67 in total

1.  Hepatocellular carcinoma.

Authors:  T Ezaki
Journal:  BMJ       Date:  1992-01-25

2.  Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.

Authors:  K Ikeda; S Saitoh; Y Suzuki; A Tsubota; I Koida; M Kobayashi; Y Arase; K Chayama; N Murashima; H Kumada
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 3.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Focal ultrasound lesions in liver cirrhosis diagnosed as regenerating nodules by fine-needle biopsy. Follow-up of 12 cases.

Authors:  G L Rapaccini; M Pompili; E Caturelli; M Anti; A Aliotta; A Cedrone; E Amadei; A Grattagliano; M M Squillante; C Rabitti
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

5.  Staging of hepatocellular carcinoma by ultrasonography, computed tomography, and angiography: the role of CT combined with arterial portography.

Authors:  F Garbagnati; C Spreafico; A Marchianò; M Salvetti; C Segura; G Piragine
Journal:  Gastrointest Radiol       Date:  1991

Review 6.  Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

Authors:  Karen E Bremner; Ahmed M Bayoumi; Morris Sherman; Murray D Krahn
Journal:  Can J Gastroenterol       Date:  2007-08       Impact factor: 3.522

Review 7.  Advances in neoplastic disease of the liver and biliary tract.

Authors:  P J Johnson; M L Wilkinson; J Karani
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

8.  Recurrence of hepatocellular carcinoma with rapid growth after spontaneous regression.

Authors:  Tomoki Nakajima; Michihisa Moriguchi; Tadashi Watanabe; Masao Noda; Nobuaki Fuji; Masahito Minami; Yoshito Itoh; Takeshi Okanoue
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

9.  Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients.

Authors:  Massimo Galia; Francesco Agnello; Gianvincenzo Sparacia; Domenica Matranga; Domenico Albano; Massimo Midiri; Roberto Lagalla
Journal:  Radiol Med       Date:  2018-03-15       Impact factor: 3.469

10.  Study of repeated arterial infusion chemotherapy with a subcutaneously implanted reservoir for advanced hepatocellular carcinoma.

Authors:  A Minoyama; M Yoshikawa; M Ebara; H Saisho; N Sugiura; M Ohto
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.